Azitra AZTR
NYSE AZTR
$0.14 +0.01 (+7.69%)
At close: Sep 30, 2026 · 4:00 PM EDT

Azitra (AZTR) Current Deferred Revenue (2022 - 2023)

Updated

Azitra's Current Deferred Revenue was $310,700 in Q2 2023.

Analysis

Azitra (AZTR) Current Deferred Revenue (2022 - 2023) Analysis & Trends

At the end of FY2022, Current Deferred Revenue at Azitra came in at $156,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Azitra 2.70 Mn 2.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 310,700.00
Dec 31, 2022 156,000.00
API Access

Azitra Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=AZTR&period=max&api_key=YOUR_API_KEY